First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

被引:24
作者
Wegen, Simone [1 ]
Roth, Katrin Sabine [2 ,3 ]
Weindler, Jasmin [2 ,3 ]
Claus, Karina [1 ]
Linde, Philipp [1 ]
Trommer, Maike [1 ]
Akuamoa-Boateng, Dennis [1 ]
van Heek, Lutz [2 ,3 ]
Baues, Christian [1 ]
Schoemig-Markiefka, Birgid [4 ]
Schomaecker, Klaus [2 ,3 ]
Fischer, Thomas [2 ,3 ]
Drzezga, Alexander [2 ,3 ,5 ,6 ]
Kobe, Carsten [2 ,3 ]
Koehler, Christhardt [7 ]
Marnitz, Simone [1 ]
机构
[1] Univ Hosp Cologne, Dept Radiat Oncol Cyberknife & Radiotherapy, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[4] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[5] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[6] Forschungszentrum Julich, Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
[7] Asklepios Hosp Grp, Dept Special Operat & Oncol Gynecol, Asklepios Clin Hamburg Altona, Hamburg, Germany
关键词
FAPI PET; cervical cancer; FDG PET; surgical lymph node staging; CHEMORADIATION; METASTASES;
D O I
10.1097/RLU.0000000000004505
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionIn several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [Ga-68]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [Ga-68]Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [F-18]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation.MethodsSeven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [Ga-68]Ga-FAPI-46- and [F-18]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP.ResultsAll 7 patients had focal uptake above background in their tumor lesions in [Ga-68]Ga-FAPI-46 PET/CT. [Ga-68]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBRmax values using liver were 32.02 and 5.15 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Median TBRmax using blood pool was 18.45 versus 6.85 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBRmax was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Overall, [Ga-68]Ga-FAPI-46 PET/CT detected more lesions compared with [F-18]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [F-18]F-FDG PET/CT and [Ga-68]Ga-FAPI-46 PET/CT, respectively.Conclusion[Ga-68]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [Ga-68]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 24 条
[1]   18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer [J].
Adam, Judit A. ;
Arkies, Hester ;
Hinnen, Karel ;
Stalpers, Lukas J. ;
van Waesberghe, Jan H. ;
Stoker, Jaap ;
van Os, Rob ;
Laan, Janna J. ;
Mom, Constantijne H. ;
van Eck-Smit, Berthe L. .
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 62 (04) :420-428
[2]   Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18f]fluorodeoxyglucose positron emission tomography scans in the para-aortic area [J].
Boughanim, Mathias ;
Leboulleux, Sophie ;
Rey, Annie ;
Pham, Chi Tuan ;
Zafrani, Yaelle ;
Duvillard, Pierre ;
Lumbroso, Jean ;
Haie-Meder, Christine ;
Schlumberger, Martin ;
Morice, Philippe .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2558-2561
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[4]   The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer [J].
Cibula, David ;
Poetter, Richard ;
Planchamp, Francois ;
Avall-Lundqvist, Elisabeth ;
Fischerova, Daniela ;
Meder, Christine Haie ;
Koehler, Christhardt ;
Landoni, Fabio ;
Lax, Sigurd ;
Lindegaard, Jacob Christian ;
Mahantshetty, Umesh ;
Mathevet, Patrice ;
McCluggage, W. Glenn ;
McCormack, Mary ;
Naik, Raj ;
Nout, Remi ;
Pignata, Sandro ;
Ponce, Jordi ;
Querleu, Denis ;
Raspagliesi, Francesco ;
Rodolakis, Alexandros ;
Tamussino, Karl ;
Wimberger, Pauline ;
Raspollini, Maria Rosaria .
RADIOTHERAPY AND ONCOLOGY, 2018, 127 (03) :404-416
[5]   68Ga-FAPI-PET/CT in patients with various gynecological malignancies [J].
Dendl, Katharina ;
Koerber, Stefan A. ;
Finck, Rebecca ;
Mokoala, Kgomotso M. G. ;
Staudinger, Fabian ;
Schillings, Lisa ;
Heger, Ulrike ;
Roehrich, Manuel ;
Kratochwil, Clemens ;
Sathekge, Mike ;
Jaeger, Dirk ;
Debus, Juergen ;
Haberkorn, Uwe ;
Giesel, Frederik L. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (12) :4089-4100
[6]   Equivalent tumor detection for early and late FAPI-46 PET acquisition [J].
Ferdinandus, J. ;
Kessler, L. ;
Hirmas, N. ;
Trajkovic-Arsic, M. ;
Hamacher, R. ;
Umutlu, L. ;
Nader, M. ;
Zarrad, F. ;
Weber, M. ;
Fendler, W. P. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) :3221-3227
[7]   Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients [J].
Ferdinandus, Justin ;
Costa, Pedro Fragoso ;
Kessler, Lukas ;
Weber, Manuel ;
Hirmas, Nader ;
Kostbade, Karina ;
Bauer, Sebastian ;
Schuler, Martin ;
Ahrens, Marit ;
Schildhaus, Hans-Ulrich ;
Rischpler, Christoph ;
Grafe, Hong ;
Siveke, Jens T. ;
Herrmann, Ken ;
Fendler, Wolfgang P. ;
Hamacher, Rainer .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) :727-734
[8]   Anatomic Location of PET-Positive Aortocaval Nodes in Patients with Locally Advanced Cervical Cancer Implications for Surgical Staging [J].
Frumovitz, Michael ;
Ramirez, Pedro T. ;
Macapinlac, Homer A. ;
Klopp, Ann H. ;
Nick, Alpa M. ;
Ramondetta, Lois M. ;
Jhingran, Anuja .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (07) :1203-1207
[9]   68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers [J].
Giesel, Frederik L. ;
Kratochwil, Clemens ;
Lindner, Thomas ;
Marschalek, Manfred M. ;
Loktev, Anastasia ;
Lehnert, Wencke ;
Debus, Juergen ;
Jaeger, Dirk ;
Flechsig, Paul ;
Altmann, Annette ;
Mier, Walter ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) :386-392
[10]   Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions [J].
Glatting, Frederik M. ;
Hoppner, Jorge ;
Liew, Dawn P. ;
van Genabith, Antonia ;
Spektor, Anna-Maria ;
Steinbach, Levin ;
Hubert, Alexander ;
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Dendl, Katharina ;
Rathke, Hendrik ;
Kauczor, Hans-Ulrich ;
Huber, Peter E. ;
Haberkorn, Uwe ;
Roehrich, Manuel .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (12) :1844-1851